These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23636084)

  • 1. Use of rimabotulinum toxin for focal hypertonicity management in children with cerebral palsy with nonresponse to onabotulinum toxin.
    Brandenburg JE; Krach LE; Gormley ME
    Am J Phys Med Rehabil; 2013 Oct; 92(10):898-904. PubMed ID: 23636084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment with botulinum toxin in neurologic pediatrics].
    Justus N; Lee SH; Berweck S; Heinen F
    Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and Efficacy of a Propofol and Ketamine Based Procedural Sedation Protocol in Children with Cerebral Palsy Undergoing Botulinum Toxin A Injections.
    Louer R; McKinney RC; Abu-Sultaneh S; Lutfi R; Abulebda K
    PM R; 2019 Dec; 11(12):1320-1325. PubMed ID: 30761757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
    Carraro E; Trevisi E; Martinuzzi A
    Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The WE-Study: does botulinum toxin A make walking easier in children with cerebral palsy?: Study protocol for a randomized controlled trial.
    Brændvik SM; Roeleveld K; Andersen GL; Raftemo AE; Ramstad K; Majkic-Tajsic J; Lamvik T; Lund B; Follestad T; Vik T
    Trials; 2017 Feb; 18(1):58. PubMed ID: 28166806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an inventory of goals using the International Classification of Functioning, Disability and Health in a population of non-ambulatory children and adolescents with cerebral palsy treated with botulinum toxin A.
    Nguyen L; Mesterman R; Gorter JW
    BMC Pediatr; 2018 Jan; 18(1):1. PubMed ID: 29301539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety profile of multilevel chemical denervation procedures using phenol or botulinum toxin or both in a pediatric population.
    Kolaski K; Ajizian SJ; Passmore L; Pasutharnchat N; Koman LA; Smith BP
    Am J Phys Med Rehabil; 2008 Jul; 87(7):556-66. PubMed ID: 18574347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of botulinum toxin in pediatric disorders.
    Gaebler-Spira D; Revivo G
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):703-25. PubMed ID: 14580033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial.
    Copeland L; Edwards P; Thorley M; Donaghey S; Gascoigne-Pees L; Kentish M; Cert G; Lindsley J; McLennan K; Sakzewski L; Boyd RN
    J Pediatr; 2014 Jul; 165(1):140-146.e4. PubMed ID: 24630348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin treatment of children with cerebral palsy - a short review of different injection techniques.
    Schroeder AS; Berweck S; Lee SH; Heinen F
    Neurotox Res; 2006 Apr; 9(2-3):189-96. PubMed ID: 16785117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A risk-stratified approach toward safely resuming OnabotulinumtoxinA injections based on dosing and ambulatory status in pediatric patients with cerebral palsy during the Coronavirus pandemic of 2019 (COVID-19).
    McLaughlin MJ; Fisher MT; Vadivelu S; Ramsey J; Ratnasingam D; McGhee E; Hartman K
    J Pediatr Rehabil Med; 2020; 13(3):273-279. PubMed ID: 33252098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiences with botulinum toxin injections against spasticity in children].
    Ramstad K; Karstensen AB; Risberg K; Bergsaker DK; Sommer FF
    Tidsskr Nor Laegeforen; 2006 Feb; 126(4):450-2. PubMed ID: 16477283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity of cerebral palsy and likelihood of adverse events after botulinum toxin A injections.
    Swinney CM; Bau K; Burton KLO; O'Flaherty SJ; Bear NL; Paget SP
    Dev Med Child Neurol; 2018 May; 60(5):498-504. PubMed ID: 29451702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over 25 Years of Pediatric Botulinum Toxin Treatments: What Have We Learned from Injection Techniques, Doses, Dilutions, and Recovery of Repeated Injections?
    Sätilä H
    Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32640636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences.
    Lorin K; Forsberg A
    Child Care Health Dev; 2016 Jul; 42(4):494-503. PubMed ID: 27198886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic adverse events after botulinum neurotoxin A injections in children with cerebral palsy.
    Paget SP; Swinney CM; Burton KLO; Bau K; O'Flaherty SJ
    Dev Med Child Neurol; 2018 Nov; 60(11):1172-1177. PubMed ID: 30146721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
    Lukban MB; Rosales RL; Dressler D
    J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Botulinum Toxin Injections on Gross Motor Function for Lower Limb Spasticity in Children with Cerebral Palsy.
    Choi JY; Kim SK; Park ES
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31717282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy.
    Williams SA; Reid S; Elliott C; Shipman P; Valentine J
    Dev Med Child Neurol; 2013 Sep; 55(9):813-20. PubMed ID: 23789782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.